Skip to main content
. 2020 Sep 18;26(9):815–821. doi: 10.1089/acm.2019.0252

Table 2.

Changes in Outcomes

Variables Mean change from baseline (95% CI)
Between-group difference (95% CI)
GAD without comorbid affective disorder GAD with comorbid affective disorder GAD with comorbid affective disorder versus GAD without comorbid affective disorder pa
HRSA       0.75
 Week 2 −5.08 (−5.8 to −4.3) −5.26 (−6.1 to −4.4) −0.17 (−1.3 to 1.0)  
 Week 4 −7.32 (−8.1 to −6.5) −7.82 (−8.7 to −6.9) −0.50 (−1.7 to 0.7)  
 Week 8 −8.90 (−9.7 to −8.1) −9.48 (−10.4 to −8.6) −0.59 (−1.8 to 0.6)  
HRSD 17       0.14
 Week 2 −3.89 (−4.7 to −3.1) −3.73 (−4.7 to −2.8) 0.16 (−1.1 to 1.4)  
 Week 4 −5.63 (−6.5 to −4.8) −6.23 (−7.2 to −5.3) −0.60 (−1.9 to 0.7)  
 Week 8 −6.86 (−7.7 to −6.0) −8.09 (−9.0 to −7.1) −1.23 (−2.5 to 0.05)  
GAD-7       0.34
 Week 2 −4.78 (−5.6 to −4.0) −4.65 (−5.5 to −3.8) 0.12 (−1.1 to 1.3)  
 Week 4 −6.26 (−7.1 to −5.4) −7.15 (−8.1 to −6.2) −0.89 (−2.1 to 0.3)  
 Week 8 −7.54 (−8.4 to −6.7) −8.05 (−9.0 to −7.1) −0.50 (−1.7 to 0.7)  
HRSD extended core       0.023
 Week 2 −1.15 (−1.6 to −0.7) −1.23 (−1.7 to −0.7) −0.075 (−0.7 to 0.6)  
 Week 4 −1.68 (−2.1 to −1.2) −2.32 (−2.8 to −1.8) −0.64 (−1.3 to 0.03)  
 Week 8 −2.19 (−2.6 to −1.7) −3.10 (−3.6 to −2.6) −0.90 (−1.6 to −0.2)  
BAI       0.87
 Week 2 −4.80 (−6.1 to −3.4) −4.59 (−6.1 to −3.0) 0.21 (−1.8 to 2.2)  
 Week 4 −7.30 (−8.7 to −5.9) −7.06 (−8.6 to −5.5) 0.24 (−1.8 to 2.3)  
 Week 8 −8.86 (−10.3 to −7.4) −9.44 (−11.0 to −7.8) −0.58 (−2.7 to 1.5)  
BDI       0.060
 Week 2 −6.05 (−7.5 to −4.6) −7.76 (−9.4 to −6.1) −1.71 (−3.9 to 0.4)  
 Week 4 −7.51 (−9.0 to −6.0) −9.36 (−11.0 to −7.7) −1.85 (−4.0 to 0.3)  
 Week 8 −9.20 (−10.7 to −7.7) −12.26 (−13.9 to −10.6) −3.06 (−5.3 to −0.8)  

All statistical tests were two-sided. Bold indicates statistical significance set at 0.05.

a

Mixed-effect p-value of the interaction term.

CI, confidence interval; HRSA, Hamilton rating scale for anxiety.